BioFactors · 2018 · 46 citations · 24 references
Veterinary MedicineEndocrinologyHealth SciencesClinical NutritionHuman NutritionInflammationCardiovascular DiseaseDiabetes MellitusMetabolic DiseaseMetabolic SyndromeOxidative StressOxidative Stress In InflammationBody Fat PercentageLipid Peroxidation BiomarkersOxidative BiomarkersOxidative Stress BiomarkersOxidative Stress In Cardiovascular DiseaseOxidative Stress In MetabolismOxidative Stress InflammationSuperoxide Dismutase 1
Obesity is an important feature of the metabolic syndrome and is associated with an increased risk of type 2 diabetes mellitus, cardiovascular disease, and some cancers. The aim of this study was to determine the relationship between body fat percentage and an imbalance of the prooxidant/antioxidant balance (PAB), serum superoxide dismutase (SOD1) and inflammation (serum hs-CRP) and increase risk of metabolic syndrome and diabetes mellitus. In this study, 9154 individuals were recruited as part of the Mashhad Stroke and Heart Association Disorder (MASHAD) study. Subjects were categorized into two groups according to body fat percentage as defined >25% in male and > 30% in female, according to gender. Biochemical factors, including serum PAB, SOD1, and hs-CRP were measured in all subjects. SPSS version 18 was used for statistical analyses for all. GraphPad Prism 6 for figures was used. Of total number of subjects (9154), 6748 (73.7%) were found to have a high body fat (BF) percentage. Serum hs-CRP and PAB were significantly higher in individuals with a high BF percentage (P < 0.05) but SOD1 was not significantly different between the two groups (P > 0.05). BF percentage, serum PAB and serum hs-CRP were significantly higher in individuals with metabolic syndrome and diabetes versus those without metabolic syndrome and diabetes mellitus (P < 0.05), however serum SOD1 was significantly lower in individuals with metabolic syndrome (P < 0.005). Oxidative stress and inflammation are two factors that may link the presence of high BF percentage with the development of metabolic syndrome, diabetes, and cardiovascular disease. © 2018 BioFactors, 45(1):35-42, 2019.
24
The Pathobiology of Diabetic Complications
Michael Brownlee · Diabetes · 2005 · 5.3K citations · Full text
David W. Haslam, W. P. T. James · The Lancet · 2005 · 3.8K citations
Veterinary Medicine, Infectious Diseases, Emerging Infectious Diseases +8
C-reactive protein: a critical update
Mark B. Pepys, Gideon M. Hirschfield · Journal of Clinical Investigation · 2003 · 3.4K citations · Full text
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
Paul M. Ridker, Julie E. Buring, Nancy R. Cook et al. · Circulation · 2003 · 2.3K citations